期刊文献+

去细胞组织工程异种瓣膜支架制备方法的比较研究 被引量:2

Studies on different decellularization procedures for heart valve tissue engineering
下载PDF
导出
摘要 目的:探讨异种组织工程心脏瓣膜生物支架的最佳制备方法。方法:将16个新鲜猪主动脉瓣分为4组,每组4个,对照组未脱细胞,实验组分别为NaCl-SDS(十二烷基硫酸钠,sodium dodecyl sulfate,SDS)法脱细胞组、胰蛋白酶法脱细胞组、曲拉通法脱细胞组,观察其形态学和免疫组织化学变化。结果:NaCl-SDS法脱细胞处理的瓣膜内皮细胞去除不彻底,细胞外基质的三维网状结构虽完整但纤维模糊,肿胀。胰蛋白酶法处理的瓣膜内皮细胞基本去除,但瓣膜支架结构改变很明显,胶原纤维肿胀,边缘毛糙,纤维网状间隙增宽不规则。曲拉通法处理的瓣膜内皮细胞去除彻底,支架结构保存完好。NaCl-SDS法、胰蛋白酶法和曲拉通法脱细胞后的瓣膜均存在一定的免疫原性,但用胰蛋白酶法和曲拉通法脱细胞后的瓣膜支架的免疫原性较NaCl-SDS法显著降低。结论:应用曲拉通法制作的瓣膜支架去内皮细胞较为彻底,不改变瓣叶支架结构,而且免疫原性小,因此曲拉通法是一种良好的组织工程瓣膜支架制作方法。 Objective:The purpose of this study is to seek better method of making tissue engineering of heart valves by testing different decellularization procedures for their potential of cell removal and their ability to preserve the matrix. Methods:Specimens of porcine aortic valves were randomly divided into the control groups and the decellularized groups. The porcine aortic valves of decellularized groups were treated with either NaCL and sodium-dodecyl-sulfate(SDS) or trypsin or Triton-X100 with specific concentration. Tissue samples were then processed for Hematoxylin Eosin and scanning electron microscopy and immunohistochemistric staining for major histocompatibility complex class Ⅰ(MHC-Ⅰ) antigen. Results:NaCL and SDS achieved only incomplete decellularization, the main components of extracellular matrix were reserved completely but the fibrous components become swelling. In contrast, trypsin removed cells completely but caused strong structural alterations. Treatment with Triton X100 achieved both complete decelluarization and preservation of the matrix structure. The decellularized valves were reserved varied level of immunogenicity. MHC-Ⅰ was decreased remarkably in trypsin and Triton-X100 groups compared with NaCL and SDS group. Conclusion: The decellularization method by Triton X100 is effective. The decellularized porcine aortic valves reserve matrix structure and have lower immunity which can be used as an ideal valve for developing tissue engineering valve.
出处 《国际心血管病杂志》 2007年第5期374-377,共4页 International Journal of Cardiovascular Disease
关键词 组织工程 心脏瓣膜 主要组织相容性复合体Ⅰ Tissue engineering Heart valve Major histocompatibility complex class Ⅰ
  • 相关文献

参考文献3

二级参考文献19

  • 1Courtmn DW, Pereira CA, Kashef V, et al. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J Biomed Mater Resc, 1994,18:655- 666
  • 2Curtil A, Pegg DE, Wilson A, et al. Freeze drying of cardiac valves in preparation for cellular repopulation.Cryobiology, 1997,34:13- 22
  • 3Sodian R, Vacanti JP, Mayer JE Jr., et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation, 2000,102 (suppl 3):Ⅲ22-Ⅲ29
  • 4Wilson GJ, Courtman DW, K1ement P, et al. Acellular matrix: a biomaterial approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg,1995,60:S353-S358
  • 5Livesey S, Boerboom L, Coleman C. Decellularized porcine heart valve as templates for host cell repopulation. Abstract: Workshop on prosthetic heart valve. Georgia Institute of Technology, 1998
  • 6Bader A, Herden T, Giere B, et al. Tissue engineering of autologous heart valve using a physiologic matrix structure. Eur J Cell Biology, 1997,74:8
  • 7Fuchs JR, Nasseri BA, Vacanti JP. Tissue engineering:a 21st century solution to surgical reconstruction.Ann Thorac Surg, 2001, 72:577-591
  • 8Shinoka T, Breuer C, Tanel R, et. al. Tissue engineering heart valves: valve leaflet replacement in a lamb model. Ann Thorac Surg, 1995,60:513-516
  • 9Bader A, Schilling T, Haverich A, et al. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg, 1998,14:279-284
  • 10John AH, John PB, Linda ML, et al. Class I and Class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg,2000,119:324-330.

共引文献26

同被引文献64

  • 1朱国臣.去细胞异体神经的形态结构及移植后的组织相容性[J].解剖学杂志,2007,30(1):4-6. 被引量:1
  • 2董念国,史嘉玮,胡平.组织工程心脏瓣膜支架的研究现状和发展趋势[J].中华实验外科杂志,2007,24(3):261-262. 被引量:21
  • 3Munger J S,Sheppard D. Cross talk among TGF-p signa-ling pathways, integrins,and the extracellular matrix[J]. Cold Spring Harb Perspect Biol,2011,3 :a0050l7.
  • 4Hoshiba T,Lu H, Kawazoe N,et al. Decellularized ma-trices for tissue engineering[J]. Expert Opin Biol Ther,2010,10:1717-1728.
  • 5Hynes R 0,Naba A. Overview of the matrisome-aninventory of extracellular matrix constituents and func-tions[J]. Cold Spring Harb Perspect Biol, 2012,4:a004903.
  • 6Chen Q,Yang Z,Sun S,et al. Adipose-derived stemcells modified genetically in vivo promote reconstructionof bone defects[J]. Cytotherapy, 2010,12 : 831-840.
  • 7Datta N,Pham Q P, Sharma U,et al. In vitro generatedextracellular matrix and fluid shear stress synergisticallyenhance 3D osteoblastic differentiation[J]. Proc NatlAcad Sci USA, 2006,106:2488-2493.
  • 8Pham Q P,Kasper F K,Scott Baggett L, et al. The in-fluence of an in vitro generated bone-like extracellular ma-trix on osteoblastic gene expression of marrow stromalcells[J]. Biomaterials,2008,29 : 2729-2739.
  • 9Liao J, Guo X,Grande-Allen K J,et al. Bioactive poly-mer/ extracellular matrix scaffolds fabricated with a flowperfusion bioreactor for cartilage tissue engineering[J].Biomaterials,2010,31:8911-8920.
  • 10Liao J, Guo X, Nelson D,et al. Modulation of osteo-genic properties of biodegradable polymer/extracellularmatrix scaffolds generated with a flow perfusion bioreac-tor[J]. Acta Biomater, 2010,6 : 2386-2393.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部